Approved, cleared and authorised are three different regulatory states with three different evidence bars, and unapproved is a fourth. Here is what each one requires, and where peptides actually sit.
Compounding a copy of an approved drug is lawful only under narrow statutory conditions. The FDA shortage listing was the condition that made GLP-1 compounding widespread, and it can be switched off.
Growth hormone, its releasing factors, the secretagogues, IGF-1 analogues and TB-500 are prohibited at all times, not only on competition day. Here is how the categories actually work.